Trial Details

Not recruiting
Basic Information
Clinical ID c2422
Identifier NCT04839315
Trial Title Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Systemic Lupus Erythematosus;Sjogren's Syndrome;Inflammatory Myositis;Psoriatic Arthritis;Gout;Ankylosing Spondylitis;Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis);Osteoarthritis
Interventions Biological: mRNA COVD19 vaccine
Participant Information
Sponsor Mayo Clinic
City -
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase EARLY_PHASE1
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -